ContraVir Pharmaceuticals, Inc. (19)
Browse by Contract Category
Contracts
-
Underwriting Agreement, dated November 24, 2020
(Filed With SEC on November 27, 2020)
-
Agreement and Plan of Merger by and among the Company, Ciclofilin Acquisition Corp., Ciclofilin Pharmaceuticals, Inc. and Robert Foster, Pharm.D., PH.D., as Stockholder...
(Filed With SEC on October 29, 2020)
-
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on May 14, 2020)
-
At Market Issuance Sales Agreement, dated February 12, 2020, by and between Hepion Pharmaceuticals, Inc. and B. Riley FBR, Inc
(Filed With SEC on February 12, 2020)
-
Form of Representatives Warrant
(Filed With SEC on November 20, 2020)
-
Form of Pre-Funded Warrant
(Filed With SEC on November 20, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on November 20, 2020)
-
Amendment No. 1 to NICAMS Purchase and Sale Agreement by and between Aurinia Pharmaceuticals Inc., Ciclofilin Pharmaceuticals Inc., an Alberta Corporation and Ciclofilin...
(Filed With SEC on November 12, 2020)
-
NICAMS Purchase and Sale Agreement by and between Ciclofilin Pharmaceuticals Corp. and Aurinia Pharmaceuticals, Inc. dated February 14, 2014
(Filed With SEC on November 12, 2020)
-
Form of Common Stock Purchase Warrant dated June 14, 2018
(Filed With SEC on November 12, 2020)
-
Promissory Note dated April 13, 2020
(Filed With SEC on October 29, 2020)
-
Form of Securities Purchase Agreement
(Filed With SEC on June 5, 2019)
-
Form of Warrant
(Filed With SEC on June 5, 2019)
-
Form of Co-Placement Agency Agreement
(Filed With SEC on June 5, 2019)
-
Form of Securities Purchase Agreement
(Filed With SEC on April 18, 2019)
-
Form of Warrant
(Filed With SEC on April 18, 2019)
-
Form of Placement Agency Agreement
(Filed With SEC on April 18, 2019)
-
Form of Unsecured Debenture issued to Investor, dated March 14, 2019
(Filed With SEC on March 19, 2019)
-
Form of Securities Purchase Agreement, dated March 13, 2019, by and among the Company and the Investor
(Filed With SEC on March 19, 2019)
